High doses of 60 plus-year-old chemo drug found to spur immune system attack on lymphoma

(Dana-Farber Cancer Institute) Cyclophosphamide, a mainstay of chemotherapy for many cancers, acts as both chemotherapy and immunotherapy at high doses, study finds.